Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats.
Our aim was to evaluate the effects of granulocyte colony-stimulating factor (G-CSF) on early cardiac arrhythmias after myocardial infarction (MI) and the impact on survival. Male Wistar rats received repeated doses of 50 mug/kg G-CSF (MI-GCSF group) or vehicle (MI group) at 7, 3, and 1 days before surgery. MI was induced by permanent occlusion of left coronary artery. The electrocardiogram was obtained before occlusion and then for 30 minutes after surgery. Events and duration of ventricular arrhythmias were analyzed. The levels of connexin43 (Cx43) were measured by Western blot immediately before MI production. Survival was significantly increased in MI-GCSF pretreated group (74% versus 52.9% MI, P < 0.05). G-CSF pretreatment also significantly reduced the ventricular premature beats when compared with the untreated-MI group (201 +/- 47 versus 679 +/- 117, P < 0.05). The number and the duration of ventricular tachycardia were smaller in the MI-G-CSF group, as well as the number of ventricular fibrillation episodes (10% versus 69% in MI, P < 0.05). Cx43 levels were significantly increased by G-CSF treatment (1.27 +/- 0.13 versus 0.86 +/- 0.11; P < 0.05). The MI size 24 hours after occlusion was reduced by G-CSF pretreatment (36 +/- 3% versus 44 +/- 2% of left ventricle in MI group; P < 0.05). The increase of Cx43 expression in the heart may explain the reduced incidence in ventricular arrhythmias in the early phases after coronary artery occlusion in rats, thus increasing survival after MI.
Baldo
Marcelo P
MP
Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.
Davel
Ana Paula C
AP
Nicoletti-Carvalho
José E
JE
Bordin
Silvana
S
Rossoni
Luciana V
LV
Mill
José G
JG
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D018031:Connexin 43 / Q000032:analysis / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D053208:Kaplan-Meier Estimate; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D016019:Survival Analysis
D018031:Connexin 43; D016179:Granulocyte Colony-Stimulating Factor